Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating prostatic hyperplasia

A technology of prostatic hyperplasia and composition, which is applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of different syndrome types, diagnostic criteria, curative effect criteria, case selection criteria, unfavorable screening of effective prescriptions and drugs, etc.

Inactive Publication Date: 2016-05-04
JINAN XINGYI MEDICAL TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still deficiencies in the treatment of this disease. For example, in clinical observation, the diagnostic criteria, curative effect criteria, and case selection criteria adopted are not uniform, and the syndrome differentiation and typing are different, which is not conducive to screening effective prescriptions and drugs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating prostatic hyperplasia
  • Medicine composition for treating prostatic hyperplasia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Embodiment 1: the pharmaceutical composition for the treatment of benign prostatic hyperplasia and preparation method thereof

[0037] The composition and parts by weight of the crude drug of the pharmaceutical composition for treating benign prostatic hyperplasia are: Tongan Lengshuihua 3085g Ailei 2225g Hydroxyevodiamine 167g Lepidolin C213g Agrimony lactone 190g;

[0038] Preparation:

[0039] (1) According to the ratio of the raw materials, take the cold water flower of the stem, Elephant, hydroxyevodiamine, liquiritigenin C, and agrimony lactone, mix them evenly, use ethanol with a concentration of 23% by weight as a solvent, and soak at 22°C Extraction, the number of times of extraction is 17 times, each extraction time is 37 hours, each solvent consumption is 31 times of the total weight of the raw material drug, and it is filtered to obtain medicinal residue A and extract A, and the extract A reclaims ethanol and concentrates to a relative Density 1.06, filter,...

Embodiment 2

[0042] Embodiment 2: the pharmaceutical composition for the treatment of benign prostatic hyperplasia and preparation method thereof

[0043] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating benign prostatic hyperplasia are: 3080g of Tongan Lengshuihua, 2230g of hydroxyevodiamine, 165g of evodiamine C216g, and 180g of Agrimony lactone;

[0044] Preparation:

[0045] (1) According to the ratio of the raw materials, take the cold water flower of the stem, Elephant, hydroxyevodiamine, liquiritigenin C, and agrimony lactone, mix them evenly, use ethanol with a concentration of 23% by weight as a solvent, and soak at 22°C Extraction, the number of times of extraction is 17 times, each extraction time is 37 hours, each solvent consumption is 31 times of the total weight of the raw material drug, and it is filtered to obtain medicinal residue A and extract A, and the extract A reclaims ethanol and concentrates to a relative ...

Embodiment 3

[0048] Embodiment 3: the pharmaceutical composition for the treatment of benign prostatic hyperplasia and preparation method thereof

[0049] The composition and parts by weight of the crude drug of the pharmaceutical composition for treating benign prostatic hyperplasia are: Tongan Lengshuihua 3090g Ailei 2220g Hydroxyevodiamine 170g Lepidolin C210g Agrimony lactone 200g;

[0050] Preparation:

[0051] (1) According to the ratio of the raw materials, take the cold water flower of the stem, Elephant, hydroxyevodiamine, liquiritigenin C, and agrimony lactone, mix them evenly, use ethanol with a concentration of 23% by weight as a solvent, and soak at 22°C Extraction, the number of times of extraction is 17 times, each extraction time is 37 hours, each solvent consumption is 31 times of the total weight of the raw material drug, and it is filtered to obtain medicinal residue A and extract A, and the extract A reclaims ethanol and concentrates to a relative Density 1.06, filter,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating prostatic hyperplasia and a preparation method thereof. The medicine composition is prepared from pilea mongolica, Centaurium pulchellum (Swartz) Druce var. altaicum Moench, Hydroxyevodiamine, CGlepidotin C and agrimolide in a matching mode. Various dosage forms can be prepared according to a normal formulation technology, and the medicine composition has the remarkable effect on treating the prostatic hyperplasia.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating benign prostatic hyperplasia and a preparation method thereof. Background technique [0002] Prostatic hyperplasia is a common and frequently-occurring disease among elderly men, and it belongs to the category of "infirmity" in traditional Chinese medicine. According to traditional Chinese medicine, dysuria is a symptom of decreased urine output, difficulty urinating, or even blockage of urination due to failure of kidney and bladder qi transformation. Unobstructed urination not only depends on the qi transformation of the kidney and bladder, but also depends on the overall relationship between the viscera, the absorption, movement, and excretion of water also depends on the qi transformation of the triple burner and the regulation and transfer of the lung, spleen and kidney. Lost, steamed. Looking at the disease l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/51A61P13/08A61K31/365A61K31/352A61K31/519
CPCA61K36/51A61K9/2031A61K9/2059A61K9/4866A61K31/352A61K31/365A61K31/519A61K36/185A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2236/55
Inventor 不公告发明人
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com